Menu Back toScientific-Communication-Key-Message-Development-Management-and-Dissemination

DIA 2018 Global Annual Meeting


Scientific Communication Key Message Development, Management, and Dissemination

    Session Chair(s)
      David B. Clemow, PhD

      David B. Clemow, PhD

      • Advisor, Scientific Communications Information Strategy
      • Eli Lilly and Company, United States
    This session will provide solutions for optimizing key message development and disclosure, including input/output links, data-to-message mapping, and awareness/access details important for strategic alignment of scientific narrative.
    Learning Objective : Share scientific key message and narrative development, management, and disclosure processes; Define the cross-functional inputs and outputs of medical/scientific key message development, including the role of advisory board relationships and workshops in message development; Provide improved/expanded awareness/access to key messages, including new methods to communicate complex medical information, leveraging key messages to maximize their value.
    Speaker(s)
      David B. Clemow, PhD

      Scientific Narrative Development: Medical Message Inputs and Disclosure Outputs

      David B. Clemow, PhD

      • Advisor, Scientific Communications Information Strategy
      • Eli Lilly and Company, United States
      Kristine  Jolliffe

      The Advisory Board ‘Laboratory’ for Key Message Development

      Kristine Jolliffe

      • Director, Scientific Content
      • Six Degrees Medical Consulting, Canada
      Wesley  Portegies, MBA

      Innovating Medical Communications: Transformative Approaches for Adding Value Through Improved Medical Decision Making

      Wesley Portegies, MBA

      • Chief Executive Officer
      • Medicalwriters.Com, United States